USE OF MAGNESIUM SULPHATE IN PRENATAL PERIOD - HARM OR BENEFIT FOR FETUS


如何引用文章

全文:

详细

Magnesium is one of the most important bioelements which is necessary for normal functioning of organisms. Magnesium is particularly important during pregnancy. Magnesium deficiency can result in a number of complications for both a woman and a fetus. Magnesium sulphate 25 % solution is widely and successfully applied in a number of obstetric cases. However, its impact on a fetus and a newborn child remains a matter of research and discussions.

作者简介

E Kamenskaya

Northern State Medical University

Email: E-kamenskaya@yandex.ru
аспирант кафедры неонатологии и перинатологии

G Chumakova

Northern State Medical University

E Aivazova

Northern State Medical University

E Zhuravleva

Northern State Medical University

参考

  1. Кошелева Н. Г. Роль гипомагниемии в акушерской патологии и методы ее коррекции // Вестник Российской ассоциации акушеров-гинекологов. 1999. № 1. С. 42—46.
  2. Adam B., Malatyalioglu E., Alvur M., Talu C. Magnesium, zinc and iron levels in pre-eclampsia // J. Matern. Fetal. Med. 2001. Vol. 10, N 4. Р 246-250.
  3. Altman D., Carroli G., Duley L., Farrell B., et al. Magpie Trial Collaboration Group. The Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial // Lancet. 2002. Vol. 359. Р 1877-1890.
  4. Azria E., Tsatsaris V., Goffinet F., Kayem G., Mignon A., Cabrol D. Magnesium sulfate in obstetrics: current data // J. Gynecol. Obstet. Biol. Reprod. (Paris). 2004. Vol. 33, N 6, Pt. 1. Р. 510.
  5. Berger R., Garnier Y. Perinatal brain injury // J. Perinat. Med. 2000. Vol. 28, N 4. Р 261-285.
  6. Bourre J. M. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain // J. Nutr. Health Aging. Part 1: micronutrients. 2006. Vol. 10, N 5. P. 377-385.
  7. Boyle C. A., Yeargin-Allsopp M., Schendel D. E., et al. Tocolytic magnesium sulfate exposure and risk of cerebral palsy among children with birth weights less than 1.750 grams // Am. J. Epidemiol. 2000. Vol. 152, N 2. Р 120-124.
  8. Crowther C. A., Hiller J. E., Doyle L. W. Magnesium sulphate for preventing preterm birth in threatened preterm labour // Cochrane Database of Systematic Reviews. 2002. Vol. 4. Art. No.: CD001060.
  9. Dwight J., Deborah G. et al. A Randomized, Controlled Trial of Magnesium Sulfate for the Prevention of Cerebral Palsy // N. Engl. J. Med. 2008. N 9. Р 895-905.
  10. Duley L., Gulmezoglu A. M. Magnesium sulphate versus lytic cocktail for eclampsia // Cochrane Database of Systematic Reviews. 2007. Vol. 4. Art. No.: CD002960.
  11. Duley L., Gülmezoglu A. M., Henderson-Smart D. J. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia // Cochrane Database of Systematic Reviews. 2003. Vol. 2. Art. No.: CD000025.
  12. Duley L., Henderson-Smart D. Magnesium sulphate versus diazepam for eclampsia // Cochrane Database of Systematic Reviews. 2003. Vol. 3. Art. No.: CD000127.
  13. Duley L., Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia // Cochrane Database of Systematic Reviews. 2003. Vol. 3. Art. No.: CD000128.
  14. Durlach J., Pages N., Bac P., Bara M., Guiet-Bara A. Magnesium deficit and sudden infant death syndrome (SIDS): SIDS due to magnesium deficiency and SIDS due to various forms of magnesium depletion: possible importance of the chronopathological form // Magnes Res. 2002. Vol. 15. Р. 78-269.
  15. Grether J. K., Hoogstrate J., Walsh-Greene E., Nelson K. B. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia // Am. J. Obstet. Gynecol. 2000. Vol. 183, N 3. Р. 717-725.
  16. Gude N. M., Stevenson J. L., Moses E. K., King R. G. Magnesium regulates hypoxia-stimulated apoptosis in the human placenta // Clin. Sci. (Lond). 2000. Vol. 98, N 4. Р. 375-380.
  17. Hallak M., Martinez-Poyer J., Kruger M. L. The effect of magnesium sulfate on fetal heart rate parameters: A randomized, placebo-controlled trial // Am. J. Obstet. Gynecol. 1999. Vol. 181, N 5. Р 1122-1127.
  18. Herschel M., Mittendorf R. J. Tocolytic magnesium sulfate toxicity and unexpected neonatal death // Perinatol. 2001. Vol. 21, N 4. Р 261-262.
  19. Kamitomo M., Sameshima H., Ikenoue T., Nishibatake M. J. Fetal cardiovascular function during prolonged magnesium sulfate tocolysis // Perinat. Med. 2000. Vol. 28, N 5. Р 377-382.
  20. Kisters K., Barenbrock M., Louwen F., et al. Membrane, intracellular, and plasma magnesium and calcium concentrations in preeclampsia // Am. J. Hypertens. 2000. Vol. 13, N 7. Р 765-769.
  21. Maged M., Steven J. Effects of Antenatal Exposure to Magnesium Sulfate on Neuroprotection and Mortality in Preterm Infants: A Meta-Analysis // Obstet Gynecol. 2009. Vol. 114, N 2, Pt. 1. Р 354-364.
  22. Matsuda Y., Kouno S., Hiroyama Y., et al. Intrauterine infection, magnesium sulfate exposure and cerebral palsy in infants born between 26 and 30 weeks of gestation // Eur. J. Obstet. Gynecol. Reprod. Biol. 2000. Vol. 91, N 2. Р 159-164.
  23. Mehta R., Petrova A. Intrapartum magnesium sulfate exposure attenuates neutrophil function in preterm neonates // Biol. Neonate. 2006. Vol. 89, N 2. Р 99-103.

版权所有 © Ekologiya cheloveka (Human Ecology), 2013


 


##common.cookie##